Summary: “Why Are Liver Cancer Rates Rising in the U.S.?” (AARP)
The video explains that liver cancer rates in the United States have tripled over the past 40 years, with a major driver being the rise in obesity and fatty liver disease. Historically, viral hepatitis and alcohol-related liver disease were the leading causes, but today fatty liver disease has become a rapidly growing risk factor.
Key points
- Obesity and fatty liver disease are increasingly linked to liver cancer. Excess fat accumulates in the liver, causing inflammation and damage that can progress to cirrhosis, which significantly increases cancer risk.
- Liver cancer is often called a “silent killer” because it usually causes few or no symptoms in its early stages, leading many cases to be diagnosed late.
- When symptoms do appear, they may include:
- Weight loss
- Upper abdominal pain
- Nausea and vomiting
- Fatigue and weakness
- Abdominal swelling
- Jaundice
- Pale or chalky stools
- Early-stage liver cancer can often be treated successfully, but advanced-stage disease is much harder to cure.
Prevention strategies highlighted
The experts emphasize that many liver cancer cases are preventable. Recommended actions include:
- Maintaining a healthy weight
- Eating a predominantly plant-based diet
- Limiting or avoiding alcohol
- Getting vaccinated against hepatitis A and B
- Detecting and managing fatty liver disease and cirrhosis early through screening and medical care
Relevance to LiverRight
The video reinforces a core LiverRight message: the growing burden of metabolic dysfunction-associated steatotic liver disease (MASLD/fatty liver disease) is reshaping liver cancer risk in the U.S. Earlier Stage Identification (“ESI”) of at-risk patients and proactive management of fatty liver disease may help prevent progression to cirrhosis and liver cancer.
